128 related articles for article (PubMed ID: 36874689)
1. Hydrocephalus As Possible Prodromal Manifestation of COVID-19: A Report of Two Cases.
Torelli G; Severino R; Caggiano C; Torelli M; de Martino L; Russo G
Cureus; 2023 Jan; 15(1):e34371. PubMed ID: 36874689
[TBL] [Abstract][Full Text] [Related]
2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
3. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
4. Normal pressure hydrocephalus associated with COVID-19 infection: a case report.
Vasconcelos TMF; Nóbrega PR; Ferreira GM; de Souza MLP; Vanderlei AS; de Castro JDV; Braga-Neto P; Sobreira-Neto MA
BMC Infect Dis; 2022 Mar; 22(1):216. PubMed ID: 35241017
[TBL] [Abstract][Full Text] [Related]
5. Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus.
Lolansen SD; Rostgaard N; Andreassen SN; Simonsen AH; Juhler M; Hasselbalch SG; MacAulay N
Fluids Barriers CNS; 2021 Dec; 18(1):54. PubMed ID: 34863228
[TBL] [Abstract][Full Text] [Related]
6. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
7. "COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment".
Munavalli GG; Guthridge R; Knutsen-Larson S; Brodsky A; Matthew E; Landau M
Arch Dermatol Res; 2022 Jan; 314(1):1-15. PubMed ID: 33559733
[TBL] [Abstract][Full Text] [Related]
8. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
9. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. A Case Report of Normal Pressure Hydrocephalus Developing After COVID-19 Infection.
Badar F; Cheema MAI; Iftikhar A
Cureus; 2023 Jan; 15(1):e33753. PubMed ID: 36793840
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
14. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19.
Parsamanesh N; Pezeshgi A; Hemmati M; Jameshorani M; Saboory E
Int J Neurosci; 2022 Sep; 132(9):917-924. PubMed ID: 33175635
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
[TBL] [Abstract][Full Text] [Related]
16. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage.
Kirtipal N; Kumar S; Dubey SK; Dwivedi VD; Gireesh Babu K; Malý P; Bharadwaj S
Infect Genet Evol; 2022 Apr; 99():105254. PubMed ID: 35217145
[TBL] [Abstract][Full Text] [Related]
17. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
18. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches.
Sodagar A; Javed R; Tahir H; Razak SIA; Shakir M; Naeem M; Yusof AHA; Sagadevan S; Hazafa A; Uddin J; Khan A; Al-Harrasi A
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883527
[TBL] [Abstract][Full Text] [Related]
19. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
20. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.
Mir MM; Mir R; Alghamdi MAA; Alsayed BA; Wani JI; Alharthi MH; Al-Shahrani AM
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
